The Medical News

The Medical News

Novel research shows that a blood test can differentiate elderly concussion patients with brain tissue damage from those without it. This finding, published in the special brain health collection of AACC's The Journal of Applied Laboratory Medicine, could help ensure that elderly patients with severe concussions receive crucial treatment for their injuries. Traumatic brain injury is a significant health concern among the elderly, with adults age 75 or older experiencing rates of traumatic brain injury-related hospitalization and death that are higher than any other age group. Most traumatic brain injuries that the elderly incur are concussions, which can cause intracranial bleeding (i.e. bleeding within the skull) that must be treated immediately. Diagnosing intracranial bleeding in the elderly comes with numerous challenges, though. The American College of Emergency Physicians recommends that all elderly concussion patients undergo computed tomography (CT) scans to check for intracranial bleeding, because issues such as age-related cognitive decline or dementia can mask signs of bleeding-induced mental impairment. However, CT scans are very expensive and expose patients to radiation, and both the healthcare system and patients would benefit from reduced CT scan use. Recently, the Food and Drug Administration authorized a blood test that identifies head injury patients who have brain tissue damage that needs to be assessed via CT scan. This blood test was not specifically designed for elderly patients, though, so a team of researchers led by Robert H. Christenson, PhD, of the University of Maryland School of Medicine in Baltimore, set out to determine how well the test performs in patients age 65 years or older. To do this, Christenson's team retrospectively analyzed data from the Prospective Clinical Evaluation of Biomarkers of Traumatic Brain Injury (ALERT-TBI) study. In this study, 1,959 adult patients with a concussion underwent both a CT scan and blood test for brain tissue damage within 12 hours of their injury. Christenson's team compared the results of the CT scan and blood test-;which measures the proteins glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal esterase L1 (UCH-L1)-;in patients 65 years of age or older and in patients younger than 65. Related Stories



Also in Industry News

CDC Coronavirus Testing Decision Likely to Haunt US for Months to Come
CDC Coronavirus Testing Decision Likely to Haunt US for Months to Come

0 Comments

CDC Coronavirus Testing Decision Likely to Haunt US for Months to Come

Read More

Cannabidiol helps fight antibiotic-resistant bacteria
Cannabidiol helps fight antibiotic-resistant bacteria

0 Comments

Cannabidiol helps fight antibiotic-resistant bacteria

Read More

Changes in surface sugarlike molecules help cancer cells to spread
Changes in surface sugarlike molecules help cancer cells to spread

0 Comments

Changes in surface sugarlike molecules help cancer cells to spread

Read More